Andrea R. Filippi talks about optimizing radiation and chemotherapy or immunotherapy combinations to improve efficacy and reduce side effects in locally advanced lung cancer. He addresses biomarkers guiding treatment, the importance of timing and sequencing, and differences between chemotherapy, immunotherapy, and targeted therapies, while highlighting promising trials and advancements for aimed at improving survival rates and quality of life for patients.

Here is the full WCLC 2024 report.